TY  - GEN
AU  - Jakubowiak,A J
AU  - Siegel,D S
AU  - Martin,T
AU  - Wang,M
AU  - Vij,R
AU  - Lonial,S
AU  - Trudel,S
AU  - Kukreti,V
AU  - Bahlis,N
AU  - Alsina,M
AU  - Chanan-Khan,A
AU  - Buadi,F
AU  - Reu,F J
AU  - Somlo,G
AU  - Zonder,J
AU  - Song,K
AU  - Stewart,A K
AU  - Stadtmauer,E
AU  - Harrison,B L
AU  - Wong,A F
AU  - Orlowski,R Z
AU  - Jagannath,S
TI  - Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study
SN  - 1476-5551
PY  - 2014///0310
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Chromosome Aberrations
KW  - Female
KW  - Humans
KW  - In Situ Hybridization, Fluorescence
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Oligopeptides
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2013.152
ER  -